To test the effect of endothelial cell-secreted IL-6 on the fraction of cancer stem cells in vivo, we generated IL-6 knockout endothelial cells (sgRNA-IL-6 HDMEC) using CRISPR/Cas9 system. The gene discussed is IL6; the disease is cancer.